Sanjar Pharma Llp - Due diligence report

A 360° intelligence report on Sanjar Pharma Llp: trust score, financial health, credit view, compliance, directors, growth and distress sign…

2014-03-04 Himatnagar, Gujarat Active
Connect MCP
Full Due-Diligence Report + Documents
  • Unlock all financial figures & 5-year trends
  • Full trust, health & credit-risk scores
  • Director details, charges & MCA documents
₹700 ₹449 Save ₹251 excl. GST
Or from ₹279/report with credits View credit packages
Company Credits – Starter
  • One credit unlocks this full due-diligence report
  • Use across any company’s report, anytime
  • Credits valid for 12 months
× ₹700 ₹279 = ₹2,790 60% off
Choose your own credit amount View credit packages

Sanjar Pharma Llp — 360° Intelligence Report

Generated from MCA filings & public records
78/100
Trust Score
Low Risk

Sanjar Pharma Llp is assessed as Low Risk with a Trust Score of 78/100. Sanjar Pharma Llp is an active limited liability partnership incorporated in 2014, operating in the Pharma sector. The company has shown revenue growth across its recent filed years. It was profitable in its latest filed year. Based on MCA filings and public records, it currently shows a moderate compliance risk and moderate financial risk profile.

Report generated on 14 Oct 2026 from the latest processed filings. Sanjar Pharma Llp snapshot & full profile →

Financial Health › Strong
Overall Assessment CautionWeakNeutralGoodStrong Strong
Compliance › Good

Automated indicators derived from public MCA / GST / EPFO records - not a credit rating, not investment, legal or financial advice. Spotted an inaccuracy? Report an error.

02

Score Card

Higher is safer · rule-based & explainable
Trust ScoreLow Risk
78/100
Overall counterparty trust - the headline number of this report.
Compliance ScoreModerate
58/100
Statutory standing - status, filings, auditor, MSME and litigation.
Financial Health ScoreModerate
70/100
Profitability, leverage and liquidity from filed statements.
Credit Risk ScoreModerate
65/100
Debt capacity, gearing and security cover for lenders.
Director Stability ScoreLow Risk
95/100
Board strength, DIN status, churn and network.
Growth ScoreLow Risk
90/100
Revenue, profit, asset and hiring momentum.
Distress ScoreLow Risk
90/100
Early-warning signals - higher means fewer warnings.
03

Financial Intelligence Dashboard

Standalone · 5 filed year(s)

Unlock the full 5-year financial dashboard with charts and year-wise figures.

Get full access

Scores and observations on this page are already computed from the real filings - only the underlying figures are locked.

04

Credit & Compliance Intelligence

Why the scores are what they are
Credit Risk Score: 65/100 Moderate
  • Profitable - internal accruals available.

Charges position: 1 open (4.52 cr) · 1 satisfied (11.00 cr).

Banking relationships (from registered charges)
LenderChargesAmount
Dena Bank1 48.0 cr
Axis Bank Limited1 48.0 cr
Compliance Score: 58/100 Moderate
  • Company status is Active as per MCA.
  • Balance sheet slightly behind (Mar 2025).
  • Flagged by authority: EPFO.
  • 1 active GST registration(s).
05

Director Intelligence

Stability score: 95/100
NameDIN / PANDesignationAppointedTenureDIN status
MOHMADAZAZ MOHMADYUNUS MUKDIWALA 01234567 Director 01/04/2018 6 yrs Approved
MOHMADMOIN KHALILAHMED MODASIYA 01234567 Director 01/04/2018 6 yrs Approved
  • 2 directors on the board.
  • No disqualified or deactivated DINs.
  • Stable board - no exits in 3 years.
  • Average tenure above 5 years.
06

Ownership & Group Intelligence

Promoter holding
64.27%
Public / other holding
35.73%
Equity shares
12,45,67,890
Equity paid-up
124.5 cr
Promoters on record
4
Ultimate holding entity
-
Subsidiaries
-
Group entities
-
Capital events
-

Full shareholding pattern, group structure & capital events →

07

Risk Intelligence Center

Growth 90 · Distress 90
Growth signals & trust indicators
Revenue acceleration: +38% over 4 year(s).
Profit expanded 1.42 year-on-year.
Asset base grew 2.1x - capacity expansion.
Net margin improved to 24%.
Operating for 12+ years.
Active EPFO - real payroll on record.
Active GST registration(s).
Distress signals & risk flags
Compliance score is weak (58/100).
1 open charge(s) registered - assets are encumbered.
08

Stakeholder Verdicts

Vendor · Banker · Investor
Vendor due diligence74/100
Favourable indicators
Suitability as a supplier / customer counterparty.
  • Check the compliance flags before onboarding.
  • No distress signals on file.
  • Financial filings available for verification.
Banker assessment65/100
Mixed indicators - deeper appraisal suggested
Indicative lending comfort for banks, NBFCs and trade credit.
  • Debt capacity assessed from filed statements.
  • 1 open charge(s) of 4.52 cr already registered.
  • Compliance gaps should be priced into terms.
Investor view80/100
Positive growth indicators
Growth quality and scalability through an investor lens.
  • 4 growth signal(s) detected.
  • Margin and return trends computable from filings.
  • Management team looks stable.
09

MCA Filings & Events Timeline

Latest 10 events
31 Mar 2025
Last AGM held
Annual general meeting
Latest balance sheet
Filed with ROC
07 Jul 2018
Charge satisfied
Dena Bank
23 May 2018
Charge created
Axis Bank Limited - 4.52 cr
21 Mar 2018
Director ceased
MOHMADZUBER ABDULRAZZAQ HARSOLIYA
24 Nov 2015
Charge created
Dena Bank - 11.00 cr
02 Dec 2014
Director ceased
SIRINBANU SHAHID HUSAIN HARSOLIA
04 Mar 2014
Incorporated
Registered with Roc Ahmedabad
Director appointed
MOHMADAZAZ MOHMADYUNUS MUKDIWALA (Designated Partner)
Director appointed
MOHMADMOIN KHALILAHMED MODASIYA (Designated Partner)
10

Key Observations

Auto-generated from the data above
Revenue grew 0.86 over the last 4 financial year(s).
Net profit margin moved from 61% to 38%.
2 active director(s) / partner(s); board looks stable and experienced.
1 active GST registration(s) indicate ongoing business operations.
EPFO-registered employer - verifiable payroll history exists.
11

Peers & Related Companies

Full peer comparison →
CompanyCINLocation
Sabarkantha Tractors Private Limited U34110GJ1990PTC013781 Sabarkantha, Gujarat
Kamadgiri Crop Science Private Limited U01100GJ2020PTC114523 Sabarkantha, Gujarat
HUMMING HAWK TECH LLP ABD-0191 Sabarkantha, Gujarat
Om Cotgin Private Limited U01405GJ2008PTC054763 Sabarkantha, Gujarat
Mishtann Agrifoods Private Limited U15135GJ2022PTC135187 Sabarkantha, Gujarat
Nidhi Multispeciality Hospital Private Limited U85100GJ2022PTC133953 Sabarkantha, Gujarat
Signum Pharma Private Limited U52399GJ2015PTC082923 Sabarkantha, Gujarat
Narendra Packaging Pvt Ltd U25200GJ1994PTC021459 Sabarkantha, Gujarat
Anish Infracon India Private Limited U45200GJ2010PTC063391 Sabarkantha, Gujarat
Nplus Consultants Private Limited U70200GJ2023PTC146399 Sabarkantha, Gujarat
12

Who Uses This Report

CA · CS · Banker · Investor · Vendor
Chartered Accountants (CA)

Verify Sanjar Pharma Llp before audits and certifications: compliance score 58/100, filing history, auditor history and charge records in one place - instead of pulling each MCA form separately.

Company Secretaries (CS)

Track statutory health of Sanjar Pharma Llp: ACTIVE compliance status, annual-return recency, director DIN status, board churn and the events timeline - the inputs for secretarial audits and due-diligence certificates.

Bankers & NBFCs

Current banker verdict: Mixed indicators - deeper appraisal suggested. Credit risk score 65/100, existing charge position and lender relationships - a first-pass credit memo before formal appraisal.

Investors & Analysts

Investor view: Positive growth indicators. Growth score 90/100, margin trends, ownership structure and peer set for Sanjar Pharma Llp - screening before a deeper diligence.

Vendors & Procurement Teams

Vendor verdict: Favourable indicators. Trust score 78/100, distress signals and MSME payment-delay disclosures - know whether Sanjar Pharma Llp pays its suppliers before you extend credit terms.

Lawyers & Compliance Teams

Litigation footprint (no cases on record), regulatory flags, charge documents trail and director networks for Sanjar Pharma Llp - groundwork for KYC, onboarding and disputes.

13

Frequently Asked Questions

Is Sanjar Pharma Llp an active company?

Sanjar Pharma Llp has MCA status “Active” with a compliance score of 58/100 (Moderate).

Is Sanjar Pharma Llp financially healthy?

Sanjar Pharma Llp has a Financial Health Score of 70/100 (Moderate) based on its filed financial statements.

Should I do business with Sanjar Pharma Llp?

Its overall Trust Score is 78/100 (Low Risk). Vendor verdict: Favourable indicators. Review the risk flags in the Risk Intelligence Center before deciding.

Who controls Sanjar Pharma Llp?

See the directors and ownership sections above for board and shareholding detail. 2 active director(s) are on record.

Does Sanjar Pharma Llp have loans or charges against its assets?

1 open charge(s) are registered against its assets, and 1 earlier charge(s) stand satisfied.

Is Sanjar Pharma Llp up to date with its ROC filings?

Balance sheet slightly behind (Mar 2025). Overall compliance score: 58/100 (Moderate).

Is it risky to lend to Sanjar Pharma Llp?

Its Credit Risk Score is 65/100 (Moderate). Banker verdict: Mixed indicators - deeper appraisal suggested.

Disclaimer: This report is generated automatically from MCA filings and public records as available in our system at the time of the last update. Scores, bands and verdicts are rule-based derived indicators of the underlying data - they are opinions generated by an algorithm, not statements of fact about the company, and are not credit ratings (within the meaning of SEBI regulations), audits, or investment, legal or financial advice. Verify from official sources and consult a qualified professional before any business, lending or investment decision. If you represent this company and believe any information is inaccurate or outdated, report it here and we will review promptly.